Saturday, November 21, 2026
Gustavo Capdevila
- A successful combination of science and political willpower has nearly eradicated four of the world’s worst tropical disease but money is need to complete the effort, according to a specialist organisation in Geneva.
The diseases are leprosy, river blindness, Chagas disease and lymphatic filariasis.
Tore Godal, director of the “Special Program for Research and Education Concerning Tropical Diseases” – an organization backed by the United Nations, the World Bank and the World Health Organization – says now is the time to finish the fight against leprosy, river blindness, Chagas disease and lymphatic filariasis.
“We are peering through a historic ‘window of opportunity’ that could lead to the imminent elimination of these diseases, “Godal said. “This is an opportunity that may not come again…it would only take a little more investment and eradication would be within our reach”.
Some of the diseases ccould be totally eliminated in fewer than 10 years although currently they are endemic over broad areas, he said.
Around 1.6 billion people are currently exposed to leprosy, a disease that causes serious facial, digital and limb deformity. Approximately 1.1 billion people live in areas where lymphatic filariasis is endemic. Those who develope full-blown filariasis present a condition known as elephantiasis which causes serious damage to genitalia and various internal organs.
The number of people exposed to Chagas disease exceeds 100 million. Chagas usually infects people when they are young, and after 20 years of infection, individuals can suddenly die of cardiac insufficiency.
Rounding out the list of diseases which could soon be eradicated is river blindness. Some 120 million people are at risk from this disease. They may lose their sight in addition to being subject to serious infection.
In recent years, the outlook on these diseases has changed significantly. Not only can they be combatted: they can even be eliminated as a result of research coupled with sustained control programs, Godal said.
Research projects undertaken by the scientific, medical and pharmaceutical communities in the last twenty years have lead to the discovery of inexpensive treatments that can be easily administered. In the case of river blindness, Ivermectina was developed, whereas leprosy and lymphatic filariasis are now controlled by a multifaceted pharmaceutical approach.
Another aspect of controlling these tropical diseases is advancement in vector control through new means of combatting the insects which carry these diseases, Godal said. Effective vector control methods include the use of bacteria to kill insects, insecticidal paints, and newly devised fumigation “bombs”.
A decisive weapon in the arsenal against these diseases is the work of cartographers which enables health personnel to determine the exact extent of areas in which disease is endemic.
In the struggle against tropical disease, the combined effort of international organizations – both governmental and non-governmental – in collaboration with national and regional governments, has resulted in the creation of efficient “cure and control” delivery systems.
In some cases, research has shown that community members are the people who can distribute medicines with maximum efficiency.
Godal pointed to efforts made by Health Ministries in Argentina, Brazil, Bolivia, Chile, Paraguay and Uruguay, which, since 1991, have invested two billion to combat Chagas disease within their national territories.
The American-based drug company, Merck, has been especially active through donations of ivermectina, the drug they invented for the treatment of river blindness. Merck donates a complete course of ivermectina to any infected individual.
In similar vein, the Nippon Foundation has promised to finance a large part of the expenditure required for the pharmaceutical treatment of leprosy over the next three years.
Godal pointed out that the type of assistance received by these three programs has been diverse. For example, the program designed to eliminate leprosy, has received considerable assistance from non-governmental agencies.
On the other hand, the struggle against onchocerciases – the parasitic disease which causes river blindness – has been conducted principally by Merck in conjunction with multilateral support by organizations such as the World Bank.
Concerning the battle against Chagas Disease, Godal underlined the primary importance of national governments.
The African Program against Onchocerciases focuses on the 18 million sufferers who are largely located in Africa, although, of the 34 countries afflicted with the disease, several are located in Latin America and the Arab world.
According to Hans Remme, an expert on river blindness, the fight against onchocerciases – a disease that has blinded 326,000 people – needs an additional infusion of money right now.
Shaik K. Noordeen, director of the Action Program for the Eradication of Leprosy, points out that the greatest concentration of this disease is in India, Brazil, and several other nations, where, unfortunately, social upheaval and civil war prevent adequate treatment of affected populations.
The estimated cost for the elimination of leprosy is 370 million dollars through the end of the century. The World Health Organization must raise sufficient funds to contribute its monetary share of 60 million.
The six countries which comprise the so-called Southern Cone countries – Argentina, Bolivia, Brazil, Chile, Paraguay and Uruguay – have committed themselves to interrupting the transmission cycle by the year 2000. Uruguay has already succeeded in eradicating the scourge.
The Southern Cone countries have created a high level research team which has produced a colorless, insecticidal paint which remains effective for more than two years.
A second insecticidal product – a fumigation “bomb” – is currently being used in Argentina. These new vector control mechanisms cost only half as much as the previous method which applied powdered insecticides.